HANSON KRISTOPHER (General Counsel) sold 7.9% of their position (13.92K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $419.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/12/2026ACC: 0001789970-26-000010
Officer· General Counsel
Since Feb 2026
-13.92K
Net shares
Net seller
$419.3K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
13.92K disposed
Non-Derivative Transactions4
Voting Common Stock
Direct
Shares
−284.00
Price / share
$27.61
Trade value
$7.84K
% of position
0.2%
5/11/2026
176.25K→175.96K
Voting Common Stock
Direct
Shares
−846.00
Price / share
$28.70
Trade value
$24.28K
% of position
0.5%
5/11/2026
175.96K→175.12K
Voting Common Stock
Direct
Shares
−6.98K
Price / share
$30.04
Trade value
$209.65K
% of position
4.0%
5/11/2026
175.12K→168.14K
Voting Common Stock
Direct
Shares
−5.81K
Price / share
$30.56
Trade value
$177.49K
% of position
3.5%
5/11/2026
168.14K→162.33K
Total
Net shares
−13.92K
Net value
-$419.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 5/11/2026 | S · Sale | −284.00 | $27.61 | $7.84K | 0.2% | 176.25K | 175.96K |
| Voting Common Stock Direct | 5/11/2026 | S · Sale | −846.00 | $28.70 | $24.28K | 0.5% | 175.96K | 175.12K |
| Voting Common Stock Direct | 5/11/2026 | S · Sale | −6.98K | $30.04 | $209.65K | 4.0% | 175.12K | 168.14K |
| Voting Common Stock Direct | 5/11/2026 | S · Sale | −5.81K | $30.56 | $177.49K | 3.5% | 168.14K | 162.33K |
| Total | −13.92K | -$419.26K | ||||||
Derivative Transactions0
No derivative transactions reported